164 related articles for article (PubMed ID: 7501467)
21. Replacement of the phosphodiester bond between U4 and G5 in the U-turn of a chemically modified hammerhead ribozyme by an amide bond.
Dunkel M; Reither V
Nucleosides Nucleotides Nucleic Acids; 2000 Apr; 19(4):749-56. PubMed ID: 10960033
[TBL] [Abstract][Full Text] [Related]
22. Cellular uptake properties of a 2'-amino/2'-O-methyl-modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA.
Fell PL; Hudson AJ; Reynolds MA; Usman N; Akhtar S
Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):319-26. PubMed ID: 9303183
[TBL] [Abstract][Full Text] [Related]
23. Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb.
Jarvis TC; Wincott FE; Alby LJ; McSwiggen JA; Beigelman L; Gustofson J; DiRenzo A; Levy K; Arthur M; Matulic-Adamic J; Karpeisky A; Gonzalez C; Woolf TM; Usman N; Stinchcomb DT
J Biol Chem; 1996 Nov; 271(46):29107-12. PubMed ID: 8910566
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of 5'-Thio-3'-O-ribonucleoside Phosphoramidites.
Li NS; Lu J; Piccirilli JA
J Org Chem; 2017 Dec; 82(23):12003-12013. PubMed ID: 29049877
[TBL] [Abstract][Full Text] [Related]
25. Minimal Hammerhead Ribozymes with Uncompromised Catalytic Activity.
O'Rourke SM; Estell W; Scott WG
J Mol Biol; 2015 Jul; 427(14):2340-7. PubMed ID: 25981451
[TBL] [Abstract][Full Text] [Related]
26. The development of a monoclonal antibody specific for a 2(')-C-allyl modification of uridine, and its use in the localization of ribozymes in vivo.
Radka SF; Pasko C; Haeberli P; Beigelman L
Anal Biochem; 2002 Aug; 307(1):40-6. PubMed ID: 12137777
[TBL] [Abstract][Full Text] [Related]
27. Enzymatic and antisense effects of a specific anti-Ki-ras ribozyme in vitro and in cell culture.
Giannini CD; Roth WK; Piiper A; Zeuzem S
Nucleic Acids Res; 1999 Jul; 27(13):2737-44. PubMed ID: 10373591
[TBL] [Abstract][Full Text] [Related]
28. Nuclease resistant hammerhead motif: from '5-ribo' to '3-ribo' model.
Matulic-Adamic J; Daniher AT; Gonzalez C; Beigelman L
Bioorg Med Chem Lett; 1999 Jan; 9(2):157-60. PubMed ID: 10021919
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of site-specifically modified oligoribonucleotides for studies of the recognition of TAR RNA by HIV-1 tat protein and studies of hammerhead ribozymes.
Slim G; Pritchard C; Biala E; Asseline U; Gait MJ
Nucleic Acids Symp Ser; 1991; (24):55-8. PubMed ID: 1841380
[TBL] [Abstract][Full Text] [Related]
30. Low-magnesium, trans-cleavage activity by type III, tertiary stabilized hammerhead ribozymes with stem 1 discontinuities.
Burke DH; Greathouse ST
BMC Biochem; 2005 Aug; 6():14. PubMed ID: 16095542
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, gene silencing, and molecular modeling studies of 4'-C-aminomethyl-2'-O-methyl modified small interfering RNAs.
Gore KR; Nawale GN; Harikrishna S; Chittoor VG; Pandey SK; Höbartner C; Patankar S; Pradeepkumar PI
J Org Chem; 2012 Apr; 77(7):3233-45. PubMed ID: 22372696
[TBL] [Abstract][Full Text] [Related]
32. A Study on Synthesis and Upscaling of 2'-
Karalė K; Bollmark M; Stulz R; Honcharenko D; Tedebark U; Strömberg R
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834019
[TBL] [Abstract][Full Text] [Related]
33. In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.
Vaish NK; Heaton PA; Fedorova O; Eckstein F
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2158-62. PubMed ID: 9482855
[TBL] [Abstract][Full Text] [Related]
34. Influence of threose nucleoside units on the catalytic activity of a hammerhead ribozyme.
Kempeneers V; Froeyen M; Vastmans K; Herdewijn P
Chem Biodivers; 2004 Jan; 1(1):112-23. PubMed ID: 17191779
[TBL] [Abstract][Full Text] [Related]
35. High cleavage activity and stability of hammerhead ribozymes with a uniform 2'-amino pyrimidine modification.
Leirdal M; Sioud M
Biochem Biophys Res Commun; 1998 Sep; 250(1):171-4. PubMed ID: 9735351
[TBL] [Abstract][Full Text] [Related]
36. Binary hammerhead ribozymes with improved catalytic activity.
Vorobjeva M; Zenkova M; Venyaminova A; Vlassov V
Oligonucleotides; 2006; 16(3):239-52. PubMed ID: 16978087
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biophysical analysis of modified thymine-containing DNA oligonucleotides.
Kawasaki F; Murat P; Li Z; Santner T; Balasubramanian S
Chem Commun (Camb); 2017 Jan; 53(8):1389-1392. PubMed ID: 28074944
[TBL] [Abstract][Full Text] [Related]
38. The roles of the conserved pyrimidine bases in hammerhead ribozyme catalysis: evidence for a magnesium ion-binding site.
Murray JB; Adams CJ; Arnold JR; Stockley PG
Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):487-94. PubMed ID: 7487885
[TBL] [Abstract][Full Text] [Related]
39. Catalytic strategies of self-cleaving ribozymes.
Cochrane JC; Strobel SA
Acc Chem Res; 2008 Aug; 41(8):1027-35. PubMed ID: 18652494
[TBL] [Abstract][Full Text] [Related]
40. LNA nucleotides improve cleavage efficiency of singular and binary hammerhead ribozymes.
Christiansen JK; Lobedanz S; Arar K; Wengel J; Vester B
Bioorg Med Chem; 2007 Sep; 15(18):6135-43. PubMed ID: 17624789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
